Use of dynamic tests of muscle function and histomorphometry of quadriceps muscle biopsies in the investigation of patients with chronic alcohol misuse and chronic fatigue syndrome.
Ischaemic lactate/ammonia tests, serum carnosinase and creatine kinase assays and percutaneous needle muscle biopsies were performed on 10 patients with chronic fatigue syndrome (CFS), and 10 with chronic alcohol misuse complaining of muscular symptoms. Basal serum lactate levels were significantly elevated in the alcohol misusers compared to the CFS patients, but all were within the reference range. Lactate profiles after ischaemic forearm exercise did not differ significantly for the two patient groups. In one patient previously diagnosed as having CFS, myoadenylate deaminase deficiency was identified on the basis of a flat ammonia response to ischaemia and absent muscle adenosine monophosphate deaminase activity. In addition, two further patients in the CFS group were subsequently shown to have other disorders: one had polymyositis and one had myopathy with mild type II fibre atrophy of unknown cause. Histomorphometric examination of muscle needle biopsy in the alcohol misusers showed features of chronic alcohol-induced skeletal myopathy in six patients and polymyositis in one patient. Type II fibre atrophy factors were significantly elevated in the alcohol group but were within the reference range in CFS patients. Dynamic tests of muscle function and muscle histology are valuable tools in excluding alternative pathology in CFS, whereas muscle histomorphometry is of the greatest value in the diagnosis of chronic alcoholic myopathy.
Wassif
W S
WS
Department of Clinical Biochemistry, Kings College School of Medicine and Dentistry, London, UK.
Sherman
D
D
Salisbury
J R
JR
Peters
T J
TJ
D000659:AMP Deaminase / Q000097:blood / Q000172:deficiency; D000328:Adult; D000437:Alcoholism / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D000641:Ammonia / Q000097:blood; D000704:Analysis of Variance; D001707:Biopsy, Needle; D003402:Creatine Kinase / Q000097:blood; D003937:Diagnosis, Differential; D004150:Dipeptidases / Q000097:blood; D015673:Fatigue Syndrome, Chronic / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D005542:Forearm / Q000098:blood supply; D006801:Humans; D007511:Ischemia; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D009133:Muscular Atrophy / Q000175:diagnosis / Q000473:pathology; D009135:Muscular Diseases / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D012016:Reference Values
D007773:Lactates; D019344:Lactic Acid; D000641:Ammonia; D003402:Creatine Kinase; D004150:Dipeptidases; C019673:aminoacyl-histidine dipeptidase; D000659:AMP Deaminase